Thalassemia differential diagnosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 20: Line 20:
|
|
* [[Genetic defect]] with alpha- or [[beta-globin]] production
* [[Genetic defect]] with alpha- or [[beta-globin]] production
* Absence of alpha or beta-globin chains
|
|
* [[Microcytic]] (<80 femtoliter)
* [[Microcytic]] (<80 femtoliter) in most cases
|
|
* Abnormal [[hemoglobin]] [[electrophoresis]] (in [[beta-thalassemia]])
* Abnormal [[hemoglobin]] [[electrophoresis]] (in [[beta-thalassemia]])
* Normal [[hemoglobin]] [[electrophoresis]] (in [[alpha-thalassemia]])
* Elevated ferritin (due to frequent transfusions and iron overload)
|
|
* [[Irritability]]  
* [[Irritability]]  
Line 34: Line 37:
* [[Iron]] chelation
* [[Iron]] chelation
* [[Gene therapy]] if available
* [[Gene therapy]] if available
* Patient education and genetic counseling
|
|
* [[Extramedullary hematopoiesis]]
* [[Extramedullary hematopoiesis]]
Line 39: Line 43:
|[[Iron deficiency anemia]]  
|[[Iron deficiency anemia]]  
|
|
* Loss of [[iron]] from [[gastrointestinal]] blood loss or [[menstrual]] [[blood loss]]
* Loss of [[iron]] from occult bleeding
* [[Gastrointestinal]] [[blood loss]]
* [[Menstrual]] [[blood loss]]
* Dietary iron deficiency
|
|
* [[Microcytic]] (<80 femtoliter)
* [[Microcytic]] (<80 femtoliter)
Line 49: Line 56:
|
|
* [[Pallor]]
* [[Pallor]]
* [[Weakness]]
* [[Weakness]]
* Positive [[occult blood]] testing (if [[Gastrointestinal bleeding|GI bleeding]])
* Positive [[occult blood]] testing (if [[Gastrointestinal bleeding|GI bleeding]])
|
|
* Intravenous or oral iron supplementation
* Intravenous or oral iron supplementation
* Blood transfusions
|
|
* [[Blood loss|Chronic blood loss]]
* [[Blood loss|Chronic blood loss]]
|
|-
|[[Hemolytic anemia]] 
* [[Normocytic anemia|Normocytic]] (80-100 femtoliter)
* [[Normocytic anemia|Normocytic]] (80-100 femtoliter)
|
|
Line 68: Line 75:
* [[Jaundice]]
* [[Jaundice]]
|
|
* Removal of offending agent
* Removal of offending agent causing hemolysis
* [[Steroids]]
* [[Steroids]]
* Alternative [[immunosuppression]]
* Alternative [[immunosuppression]]

Revision as of 20:36, 16 November 2017

Thalassemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Thalassemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Thalassemia differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Thalassemia differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Thalassemia differential diagnosis

CDC on Thalassemia differential diagnosis

Thalassemia differential diagnosis in the news

Blogs on Thalassemia differential diagnosis

Directions to Hospitals Treating Thalassemia

Risk calculators and risk factors for Thalassemia differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Shyam Patel [2] Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Overview

Differential Diagnosis

Characteristic/Parameter Etiology Mean corpuscular volume Laboratory abnormalities Physical examination Treatment Other associated abnormalities
Thalassemia
Iron deficiency anemia
  • Intravenous or oral iron supplementation
  • Blood transfusions
Hemolytic anemia
Sideroblastic anemia

Or

Anemia of chronic disease
Thalassemia
Iron deficiency anemia
  • Intravenous or oral iron supplementation
Erythropoietin deficiency
  • Epoetin alfa 50-100 units/kg 3 times weekly
  • Darbepoietin 0.45 mcg/kg weekly or 0.75 mcg/kg every 2 weeks[1]
Vitamin B12 or folate deficiency


References

  1. Platzbecker U, Symeonidis A, Oliva EN, Goede JS, Delforge M, Mayer J; et al. (2017). "A phase 3 randomized placebo-controlled trial of darbepoetin alfa in patients with anemia and lower-risk myelodysplastic syndromes". Leukemia. 31 (9): 1944–1950. doi:10.1038/leu.2017.192. PMC 5596208. PMID 28626220.

Template:WH Template:WS